The Journal of Prevention of Alzheimer s Disease · 2025 · 10 citations · 28 references
MedicineNeurologyNeuroscienceAgingDementiaHepatologyAlzheimer DiseaseBiomarkers Of Liver InjuryHepatic Function TestingHepatic ImpairmentLiver DiseaseLiver Function TestsAlzheimer Disease ProgressionCohort Study InvestigationEarly DiagnosisHepatic Function ChangesLongitudinal Cohort AnalysisLongitudinal Cohort StudiesSerum Alanine AminotransferaseSerum Aspartate Aminotransferase
IMPORTANCE: The neuropathological links underlying the association between changes in liver function and AD have not yet been clearly elucidated. OBJECTIVE: We aimed to examine the relationship between liver function markers and longitudinal changes in Alzheimer's disease (AD) core pathologies. DESIGN: Data from the Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer's Disease, a longitudinal cohort study initiated in 2014, were utilized. SETTING: Community and memory clinic setting. PARTICIPANTS: Three hundred forty-seven older adults. MAIN OUTCOME AND MEASURES: Participants underwent baseline and 2-year follow-up evaluations, including liver function assessments and various brain imaging techniques, such as amyloid and tau PET, FDG-PET, and MRI). Liver function indicators [alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin] were examined as exposure variables. RESULTS: < 0.001). In contrast, AST alone showed no significant association with changes of AD pathologies. CONCLUSIONS AND RELEVANCE: The findings suggest a possible link between lower liver function and the accumulation of core AD pathologies in the brain. These results also support the possibility that the liver-brain axis could be a potential target for therapeutic or preventive strategies against AD.
28
Guy M. McKhann, David S. Knopman, Howard Chertkow et al. · Alzheimer s & Dementia · 2011 · 18.8K citations · Full text
Marilyn S. Albert, Steven T. DeKosky, Dennis W. Dickson et al. · Alzheimer s & Dementia · 2011 · 10.2K citations